Jennifer Effie Amengual, MD

Articles by Jennifer Effie Amengual, MD

Tazemetostat and Belinostat Synergy in Relapsed/Refractory Lymphoma

May 10th 2026

Jennifer Effie Amengual, MD, detailed a clinical trial evaluating the dual epigenetic combination of tazemetostat and belinostat to treat T-cell lymphomas.

Latest Updated Articles

Trending on CancerNetwork

FDA Clears AI Stratification Tool in HR+/HER2– Invasive Breast Cancer

Zenocutuzumab Earns FDA National Priority Voucher in Cholangiocarcinoma

124 Real-World Progression-Free Survival 2 and Tumor Response of CDK4/6is + Aromatase Inhibitor in Patients With HR+/HER2– Metastatic Breast Cancer

FDA Approves Zenocutuzumab in NRG1+ Cholangiocarcinoma Post Systemic Therapy

123 Real-World Patient and Caregiver Experiences With Breast Cancer (BC) Risk of Recurrence (ROR) in the US: Results of an Online Survey and Social Media Analysis